Coronavirus
To visit the Select Subcommittee on the Coronavirus Crisis, click here.
In light of the ongoing Coronavirus crisis, the Committee on Oversight and Reform has been conducting oversight of our nation's preparedness for, and response to, the outbreak. The Committee's top priority is promoting the health and safety of the American people, and the information below is from the Committee's investigative activities, the Centers for Disease Control and Prevention (CDC), and other sources.
Oversight Committee Hearing Mentioned on NBC's Meet the Press, March 15, 2020:
Full Committee Activities:
More on Coronavirus
Washington, D.C. (May 4, 2020)—Today, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, issued the following statement after the Food and Drug Administration (FDA) revised its policy on serological antibody testing to address wide gaps in the Trump Administration's handling of serology tests identified in the Subcommittee's investigation:
Washington, D.C. (May 4, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and Committee Member Jackie Speier sent a letter to Jaguar Health seeking information about the company's recent decision to increase the price of Mytesi while seeking approval to use the drug for coronavirus patients.
A "parallel" COVID-19 pandemic may be occurring with "far less scrutiny in another setting housing vulnerable seniors"
Washington, D.C. (Apr. 30, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, Rep. Gerald E. Connolly, the Chairman of the Subcommittee on Government Operations, Rep. Peter King, Ranking Member of the House Committee on Homeland Security's Emergency Preparedness Subcommittee, and Rep.
Washington, D.C. (Apr. 29 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued this statement following a report that the Federal Emergency Management Agency (FEMA) is planning to deactivate the National Response Coordination Center:
Washington, D.C. (Apr. 29, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued the following statement after Speaker Nancy Pelosi named her to the House Select Committee on the Coronavirus Crisis:
On Wednesday, April 29, 2020, at 2:00 p.m. EST,the Subcommittee will hold a telephonebriefingwith Special Inspector General for Afghanistan Reconstruction (SIGAR) John F. Sopko on recent developments in Afghanistan and SIGAR's mostrecent quarterly reporton the status of reconstruction in Afghanistan. On Wednesday, April 29, 2020, at 2:00 p.m.
On Wednesday, April 29, 2020, at 2:00 p.m. EST,the Subcommittee will hold a telephonebriefingwith Special Inspector General for Afghanistan Reconstruction (SIGAR) John F. Sopko on recent developments in Afghanistan and SIGAR's mostrecent quarterly reporton the status of reconstruction in Afghanistan. On Wednesday, April 29, 2020, at 2:00 p.m.
Washington, D.C. (Apr. 29, 2020)—Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, sent a letter to the Food and Drug Administration (FDA) pressing for compliance in the Subcommittee's investigation into the agency's policies governing serological testing for coronavirus.
Washington, D.C. (Apr. 28, 2020)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, issued the following statement after officials from the Federal Emergency Management Agency (FEMA) and Department of Health and Human Services (HHS) acknowledged in congressional briefings that states continue to face shortages of personal protective equipment and coronavirus testing supplies: